While the global coronavirus (COVID-19) pandemic caused all major stock market indices to fall sharply in March 2020, both the extent of the decline at this time, and the shape of the subsequent recovery, have varied greatly. For example, on March 15, 2020, major European markets and traditional stocks in the United States had shed around ** percent of their value compared to January *, 2020. However, Asian markets and the NASDAQ Composite Index only shed around ** to ** percent of their value. A similar story can be seen with the post-coronavirus recovery. As of November 14, 2021 the NASDAQ composite index value was around ** percent higher than in January 2020, while most other markets were only between ** and ** percent higher. Why did the NASDAQ recover the quickest? Based in New York City, the NASDAQ is famously considered a proxy for the technology industry as many of the world’s largest technology industries choose to list there. And it just so happens that technology was the sector to perform the best during the coronavirus pandemic. Accordingly, many of the largest companies who benefitted the most from the pandemic such as Amazon, PayPal and Netflix, are listed on the NADSAQ, helping it to recover the fastest of the major stock exchanges worldwide. Which markets suffered the most? The energy sector was the worst hit by the global COVID-19 pandemic. In particular, oil companies share prices suffered large declines over 2020 as demand for oil plummeted while workers found themselves no longer needing to commute, and the tourism industry ground to a halt. In addition, overall share prices in two major stock exchanges – the London Stock Exchange (as represented by the FTSE 100 index) and Hong Kong (as represented by the Hang Seng index) – have notably recovered slower than other major exchanges. However, in both these, the underlying issue behind the slower recovery likely has more to do with political events unrelated to the coronavirus than it does with the pandemic – namely Brexit and general political unrest, respectively.

As of November 14, 2021, all S&P 500 sector indices had recovered to levels above those of January 2020, prior to full economic effects of the global coronavirus (COVID-19) pandemic taking hold. However, different sectors recovered at different rates to sit at widely different levels above their pre-pandemic levels. This suggests that the effect of the coronavirus on financial markets in the United States is directly affected by how the virus has impacted various parts of the underlying economy. Which industry performed the best during the coronavirus pandemic? Companies operating in the information technology (IT) sector have been the clear winners from the pandemic, with the IT S&P 500 sector index sitting at almost ** percent above early 2020 levels as of November 2021. This is perhaps not surprising given this industry includes some of the companies who benefitted the most from the pandemic such as ************** and *******. The reason for these companies’ success is clear – as shops were shuttered and social gatherings heavily restricted due to the pandemic, online services such shopping and video streaming were in high demand. The success of the IT sector is also reflected in the performance of global share markets during the coronavirus pandemic, with tech-heavy NASDAQ being the best performing major market worldwide. Which industry performed the worst during the pandemic? Conversely, energy companies fared the worst during the pandemic, with the S&P 500 sector index value sitting below its early 2020 value as late as July 2021. Since then it has somewhat recovered, and was around ** percent above January 2020 levels as of October 2021. This reflects the fact that many oil companies were among the share prices suffering the largest declines over 2020. A primary driver for this was falling demand for fuel in line with the reduction in tourism and commuting caused by lockdowns all over the world. However, as increasing COVID-19 vaccination rates throughout 2021 led to lockdowns being lifted and global tourism reopening, demand has again risen - reflected by the recent increase in the S&P 500 energy index.

In the first quarter of 2020, global stock indices posted substantial losses that were triggered by the outbreak of COVID-19. The period from March 6 to 18 was particularly dramatic, with several stock indices losing more than ** percent of their value. Worldwide panic hits markets From the United States to the United Kingdom, stock market indices suffered steep falls as the coronavirus pandemic created economic uncertainty. The Nasdaq 100 and S&P 500 are two indices that track company performance in the United States, and both lost value as lockdowns were introduced in the country. European markets also recorded significant slumps, which triggered panic selling among investors. The FTSE 100 – the leading share index of companies in the UK – plunged by as much as ** percent in the opening weeks of March 2020. Is it time to invest in tech stocks? The S&P 500 is regarded as the best representation of the U.S. economy because it includes more companies from the leading industries. However, helped in no small part by its focus on tech companies, the Nasdaq 100 has risen in popularity and seen remarkable growth in recent years. Global demand for digital technologies has increased further due to the coronavirus, with remote working and online shopping becoming part of the new normal. As a result, more investors are likely to switch to the tech stocks listed on the Nasdaq 100.

This dataset contains the stock prices of Google since the COVID-19 pandemic began. There are 7 columns in this dataset:

A monetary policy reaction function typically describes how a central bank’s policy rate responds to changes in economic fundamentals, such as inflation and labor market conditions, and other factors. We use minute-by-minute data on two-year Treasury yields to study the market-expected monetary policy reaction function from 2004 to 2024. We find that financial markets expected monetary policy to react more aggressively to inflation news during 2022–2024 than in the pre-COVID-19-pandemic period. In addition, we find that the sensitivity of the two-year Treasury yield to economic news other than core inflation and labor market conditions has decreased over time. This time-varying sensitivity to changes in economic fundamentals may reflect an actual change in the FOMC’s reaction function, or it may be associated with the fact that market participants became more attentive to inflation news after the pandemic recession period.

Snapshot img

Europe Coronavirus Test Kits Market Size 2024-2028

The coronavirus test kits market in Europe size is forecast to decrease by USD 1.89 billion at a CAGR of -72.5% between 2023 and 2028.

The European coronavirus test kits market is experiencing significant growth due to the increasing demand for rapid diagnostic solutions. The emergence of SARS-CoV-2 variants, such as the Delta variant, has highlighted the importance of accurate and timely testing. Oropharyngeal swabs, nasal swabs, and sputum samples are commonly used for diagnosing COVID-19 infections. Point-of-Care (PoC) kits have gained popularity due to their convenience and quick results. However, the accuracy of diagnostic tests remains a challenge, with the Indian Council of Medical Research (ICMR) and the Health Ministry reporting false positives and negatives. The market is expected to continue its expansion as the world navigates the ongoing pandemic.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The European coronavirus test kits market is witnessing significant growth due to the ongoing pandemic caused by SARS-CoV-2. The demand for test kits is driven by the need for early detection and rapid screening of infected individuals to prevent the spread of the virus within communities. According to the medical device database from GlobalData, RT-PCR tests remain the gold standard for diagnosing SARS-CoV-2 infection. These tests detect viral genetic material from human nasal samples, providing accurate results. However, the time-consuming nature of these tests and the requirement for specialized equipment have led to the emergence of alternative solutions, such as SARS-CoV-2 antigen tests.
Moreover, rapid antigen tests, also known as point-of-care (PoC) kits, offer user-friendly solutions for healthcare systems. These tests provide results within minutes, making them ideal for mass screening in various settings, including schools, workplaces, and airports. The Delta variant and the emerging Omicron variant of SARS-CoV-2 have added to the urgency for effective testing solutions. The European Union has been proactive in addressing this need, with initiatives such as the European Health Union and the EU Digital COVID Certificate system. The European coronavirus test kits market is expected to continue its growth trajectory, driven by the ongoing pandemic and the need for regular testing to ensure public health and safety

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Government
  Non government


Type

  Rapid test kit
  RT-PCR
  Others


Geography

  Europe

    Germany
    UK
    France

By End-user Insights

The government segment is estimated to witness significant growth during the forecast period.

In Europe, various diagnostic techniques are utilized to identify COVID-19 cases, with WHO recommending that countries with limited testing capacity or inexperienced national laboratories send their initial positive and negative samples to five referral laboratories in Europe for confirmatory testing. These laboratories include the German coronavirus diagnostic working group at Charite and Robert Koch Institute in Berlin, Erasmus Medical Center in Rotterdam, the Institute Pasteur in Paris, and the Respiratory Virus Unit at Public Health England. Additionally, several other laboratories in Belgium, Luxembourg, the Netherlands, and Spain offer diagnostic testing support. In the UK, Public Health England (PHE) regional laboratories provide testing facilities alongside WHO referral laboratories. As the world awaits vaccinations and booster doses, public awareness remains crucial. During the flu season, mask mandates and social distancing measures continue to be essential preventative measures.

Get a glance at the market report of share of various segments Request Free Sample

Market Dynamics

Our Europe Coronavirus Test Kits Market researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of the European coronavirus Test Kits Market?

Rising adoption of rapid coronavirus test kits is the key driver of the market.

In Europe, the coronavirus pandemic has put immense pressure on healthcare systems, particularly in terms of diagnostic capabilities. To mitigate this challenge, European governments have prioritized expanding their testing capacity through various means. In 2022, there was a significant push to distribute coronavirus test kits across

A substantial fraction of k-12 schools in the United States closed their in-person operations during the COVID-19 pandemic. These closures may have altered the labor supply decisions of parents of affected children due to a need to be at home with children during the school day. In this paper, we examine the impact of school closures on parental labor market outcomes. We test whether COVID-19 school closures have a disproportionate impact on parents of school-age children (ages 5-17 years old). Our results show that both women’s and men’s work lives were affected by school closures, with both groups seeing a reduction in work hours and the likelihood of working full-time but only women being less likely to work at all. We also find that closures had a corresponding negative effect on the earnings of parents of school-aged children. These effects are concentrated among parents without a college degree and parents working in occupations that do not lend themselves to telework, suggesting that such individuals had a more difficult time adjusting their work lives to school closures.

Since the COVID-19 pandemic, the United States has experienced sharply rising then falling inflation alongside persistent labor market imbalances. This Economic Commentary interprets these macroeconomic dynamics, as represented by the Beveridge and Phillips curves, through the lens of a macroeconomic model. It uses the structure of the model to rationalize the debate about whether the US economy can expect a hard or soft landing. The model is surprised by the resiliency of the labor market as the US economy experienced disinflation. We suggest that the model’s limited ability to capture this resiliency is a feature of using a linear model to forecast the historically unprecedented movements seen after the pandemic among inflation, unemployment, and vacancy rates. We explain how, by adjusting the model to mimic congestion in a tight labor market and greater wage and price flexibility in a high-inflation environment, as during the post-pandemic period, the model can then capture what has been a path consistent with a soft landing.

The global market for clinical treatments for COVID-19 experienced significant growth during the pandemic's peak (2019-2024), driven by urgent medical needs and substantial government funding for research and development. While the acute phase of the pandemic has subsided, the market continues to evolve, albeit at a moderated Compound Annual Growth Rate (CAGR). This sustained growth reflects the ongoing need for effective treatments to manage long COVID, prevent severe illness in vulnerable populations, and prepare for potential future outbreaks. The market is segmented based on treatment modality (antivirals, monoclonal antibodies, immunotherapies, etc.), administration route (oral, intravenous, etc.), and patient population (adults, children, immunocompromised). Key players like Moderna, Pfizer, and Janssen Pharmaceuticals have established themselves, but the landscape is also characterized by the presence of smaller biotech companies, fostering innovation and competition in developing novel therapies. The market's future trajectory is influenced by factors such as the emergence of new COVID-19 variants, advancements in antiviral and immune-modulating therapies, evolving healthcare policies, and sustained investment in pandemic preparedness. The sustained growth in the COVID-19 treatment market is projected to continue, albeit at a slower pace than the initial surge. Factors like the development of new variants, the need for broader access to treatment in lower-income countries, and ongoing research into long COVID-related complications are all contributing to the continued market demand. The market's structure is likely to see increased consolidation as larger pharmaceutical companies acquire smaller biotech firms with promising treatment pipelines. The focus is shifting from emergency response to long-term management and preventive strategies, suggesting a move towards a more sustainable market based on prevention, early intervention, and targeted therapies. The success of future market growth will heavily depend on the successful development and widespread adoption of therapies that address the evolving challenges presented by the virus and its long-term effects.

In just *** week in March 2020, investors with a short position on Tesla stock were able to generate profits of over *** billion U.S. dollars. From around mid-February 2020, the global coronavirus (COVID-19) pandemic sent global stock markets into a tailspin as entire countries closed down their economy in order to slow the spread of the virus. While the effect on financial markets was catastrophic for many most investors, once class of investor was able to profit handsomely off the disaster - short sellers. Short selling is a process whereby investors effectively borrow a certain number of shares for a period of time, with the aim of selling them when the price is high, then repurchasing at a lower price in order to return them.

BackgroundLong-term health conditions can affect labour market outcomes. COVID-19 may have increased labour market inequalities, e.g. due to restricted opportunities for clinically vulnerable people. Evaluating COVID-19’s impact could help target support.AimTo quantify the effect of several long-term conditions on UK labour market outcomes during the COVID-19 pandemic and compare them to pre-pandemic outcomes.MethodsThe Understanding Society COVID-19 survey collected responses from around 20,000 UK residents in nine waves from April 2020-September 2021. Participants employed in January/February 2020 with a variety of long-term conditions were matched with people without the condition but with similar baseline characteristics. Models estimated probability of employment, hours worked and earnings. We compared these results with results from a two-year pre-pandemic period. We also modelled probability of furlough and home-working frequency during COVID-19.ResultsMost conditions (asthma, arthritis, emotional/nervous/psychiatric problems, vascular/pulmonary/liver conditions, epilepsy) were associated with reduced employment probability and/or hours worked during COVID-19, but not pre-pandemic. Furlough was more likely for people with pulmonary conditions. People with arthritis and cancer were slower to return to in-person working. Few effects were seen for earnings.ConclusionCOVID-19 had a disproportionate impact on people with long-term conditions’ labour market outcomes.

For the seventh year in a row, the U.S. biological product market recorded growth in sales value, which increased by 11% to $50.4B in 2019. The biological product market is one of the few markets where the demand is increasing amid the pandemic. The use of blood plasma from patients with antibodies to coronavirus to treat other patients is one of the currently available kinds of therapy for COVID-19. In addition, the development of a vaccine against coronavirus constitutes a super-urgent task, which may lead to an increase in the market should a mass vaccination start.

Snapshot img

North America Coronavirus Test Kits Market Size 2024-2028

The North America coronavirus test kits market size is forecast to increase by USD -1419 million, at a CAGR of -71.7% between 2023 and 2028.

The market is experiencing significant momentum due to the integration of COVID-19 testing into routine healthcare check-ups. This trend underscores the growing importance of diagnostic testing in managing the ongoing pandemic and maintaining public health. Simultaneously, the market is witnessing the launch of new COVID-19 test kits, offering enhanced accuracy, convenience, and speed. In the fields of human genetic testing, forensic sciences, pathogen detection, oncology testing, blood screening, and POC molecular diagnostics, the demand for accurate and reliable test kits is increasing. The use of COVID-19 test kits in various applications, from infectious disease diagnosis to research and development, is expanding. However, the market faces challenges as well. The easy availability of counterfeit COVID-19 test kits poses a significant threat to market growth and consumer trust. Companies must navigate this challenge by implementing robust quality control measures and collaborating with regulatory authorities to ensure the authenticity and efficacy of their test kits.
By focusing on innovation, quality, and regulatory compliance, market participants can capitalize on the growing demand for COVID-19 testing and effectively address the challenges presented by the counterfeit market.

What will be the size of the North America Coronavirus Test Kits Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2020-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The North American coronavirus test kits market is witnessing significant activity and trends in high-throughput screening and data reporting systems. ELISA testing, immunofluorescence assay, and lateral flow immunoassay are commonly used diagnostic techniques, undergoing clinical and external validation for assay reproducibility and calibration procedures. Genetic sequencing plays a crucial role in infection control measures and viral load quantification, while automated testing systems streamline test result interpretation. Serial dilution and standard curves are essential for performance evaluation and method comparison. Fluorescence immunoassay and chemiluminescence immunoassay contribute to quantitative results, with biosafety protocols ensuring test accuracy and safety.
Waste disposal guidelines and infection control measures are integral to the diagnostic workflow. Cost effectiveness is a critical factor, with serial dilution, calibration procedures, and viral load quantification contributing to test affordability. Infection control measures, limit of quantitation, and assay reproducibility are key considerations for biosafety and accurate test results.

How is this market segmented?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2020-2022 for the following segments.

End-user

  Government
  Non-government


Type

  Rapid test kit
  RT-PCR
  Others


Geography

  North America

    US
    Canada
    Mexico

By End-user Insights

The government segment is estimated to witness significant growth during the forecast period.

In response to the ongoing COVID-19 pandemic, governments at all levels have significantly increased their consumption of coronavirus test kits for public health initiatives. These programs, which include testing for both symptomatic and asymptomatic individuals, have led to a surging demand for test kits. One notable example is the White House's introduction of COVIDTests.Gov in January 2022, which enabled American households to order free at-home test kits, resulting in a substantial requirement for these kits from the federal government. Antibody tests, negative controls, and the limit of detection are essential components of these test kits, ensuring diagnostic accuracy. Assay validation and false positive rate are critical factors in the selection and implementation of these tests.

Saliva sample collection has emerged as a convenient and non-invasive alternative to nasal or throat swabs for some tests, while RT-PCR technology and reverse transcription form the basis of molecular diagnostic tests. FDA EUA authorization and CE marking certification are essential regulatory approvals for these test kits, ensuring their safety and efficacy. Home testing kits have gained popularity due to their convenience, while storage conditions and sample processing are crucial factors in maintaining test kit specificity. Point-of-care testing and rapid diagnostic tests offer quick results, making them valuable tools in controlling the spread of

While some UK industries have inevitably suffered during the COVID-19 pandemic and the associated lockdown, IBISWorld has looked at those that are expected to have benefited.

Snapshot img

Coronavirus Test Kits Market Size 2024-2028

The coronavirus test kits market size is forecast to decrease by USD 6.81 billion at a CAGR of -72.6% between 2023 and 2028.

The market is experiencing significant growth due to several key factors. One major trend is the increasing adoption of rapid testing solutions, particularly in healthcare settings and point-of-care diagnostics. This is driven by the need for quick results to support timely treatment and containment efforts. Another factor is the rising demand for testing in developing countries with poor healthcare infrastructure, where RT-PCR testing may not be readily available. POC testing solutions include rapid antigen tests and immunoassay test strips. Additionally, the emergence of new technologies such as mRNA vaccines and shorter assay durations are expanding testing capacity and providing financial assistance to healthcare systems. The market is also witnessing an increased focus on obtaining Emergency Use Authorization (EUA) for coronavirus test kits from regulatory bodies to ensure their widespread availability and use. Overall, these trends are shaping the future of the market and driving its growth.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market in the United States is witnessing significant growth due to the ongoing pandemic. The demand for these kits is primarily driven by the need for accurate and timely diagnosis of the virus to prevent its further spread. The regulatory bodies in the US, such as the Food and Drug Administration (FDA), have been approving various diagnostic solutions for the detection of coronavirus. These solutions include molecular tests, such as Reverse Transcription Polymerase Chain Reaction (RT-PCR) assay kits, and rapid diagnostic tests, including antigen and antibody tests. The market for in-vitro diagnostic tests, including coronavirus test kits, is expected to experience substantial growth in the coming years. The growth is attributed to the increasing number of diagnostic centers and healthcare facilities offering testing services, as well as the rising number of asymptomatic patients requiring testing.
Moreover, the market for point-of-care (POC) testing is also gaining traction, as these tests offer faster results and can be conducted at various settings, including hospitals, urgent care centers, and even at home. The specimens used for coronavirus testing include nasopharyngeal swabs, oropharyngeal swabs, and nasal swabs. These swabs are collected from patients and sent to diagnostic laboratories for analysis using the approved diagnostic solutions. The use of coronavirus test kits is essential for patient treatment and management, as early detection and isolation of infected individuals can help prevent the spread of the virus. The market for these kits is expected to remain strong, as long as the pandemic continues to pose a threat to public health. In conclusion, the market in the United States is witnessing significant growth due to the ongoing pandemic. The market is driven by the need for accurate and timely diagnosis of the virus, regulatory approvals, and the increasing number of diagnostic centers and healthcare facilities offering testing services. POC testing solutions, such as rapid antigen tests and immunoassay test strips, are gaining popularity due to their faster turnaround time and convenience. The market is expected to remain strong, as long as the pandemic continues to pose a threat to public health.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

End-user

  Government
  Non government


Type

  Rapid test kit
  RT-PCR
  Others


Geography

  Asia

    China
    India


  Europe



  North America

    US


  Rest of World (ROW)

By End-user Insights

The government segment is estimated to witness significant growth during the forecast period.

The market is experiencing significant growth due to the rising number of confirmed COVID-19 cases worldwide. Government organizations play a crucial role in driving this market, as they offer testing services for SARS-CoV-2. In both developed and developing countries, the adoption of coronavirus test kits is increasing to meet the demands of clinical settings. Nasopharyngeal and oropharyngeal swabs are commonly used for viral sampling in coronavirus testing. The sensitivity, viral load, and detection rate of these tests are critical factors in determining accurate results. In-vitro diagnosis using coronavirus test kits is becoming increasingly essential in identifying infected individuals and controlling the spread of the virus.

Government healthcare organi

Understanding how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in 2019 is critical to preventing zoonotic outbreaks before they become the next pandemic. The Huanan Seafood Wholesale Market in Wuhan, China, was identified as a likely source of cases in early reports but later this conclusion became controversial. We show the earliest known COVID-19 cases from December 2019, including those without reported direct links, were geographically centered on this market. We report that live SARS-CoV-2 susceptible mammals were sold at the market in late 2019 and, within the market, SARS-CoV-2-positive environmental samples were spatially associated with vendors selling live mammals. While there is insufficient evidence to define upstream events, and exact circumstances remain obscure, our analyses indicate that the emergence of SARS-CoV-2 occurred via the live wildlife trade in China, and show that the Huanan market was the epicenter of the COVID-19 pandemic.

Context

The 2019–20 coronavirus pandemic is an ongoing global pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus first emerged in Wuhan, Hubei, China, in December 2019. On 11 March 2020, the World Health Organization declared the outbreak a pandemic. As of 11 March 2020, over 126,000 cases have been confirmed in more than 110 countries and territories, with major outbreaks in mainland China, Italy, South Korea, and Iran. More than 4,600 have died from the disease and 67,000 have recovered.

Content

2019 Novel Coronavirus (2019-nCoV) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. Early on, many of the patients in the outbreak in Wuhan, China reportedly had some link to a large seafood and animal market, suggesting animal-to-person spread. However, a growing number of patients reportedly have not had exposure to animal markets, indicating person-to-person spread is occurring. At this time, it’s unclear how easily or sustainably this virus is spreading between people - CDC

This dataset has information on the number of affected cases, deaths and recovery from 2019 novel coronavirus. Please note that this data was scrapped from https://www.worldometers.info/coronavirus/.This data is solely for education purposes only.

More - Find More Exciting🙀 Datasets Here - An Upvote👍 A Dayᕙ(`▿´)ᕗ , Keeps Aman Hurray Hurray..... ٩(˘◡˘)۶Hehe

Acknowledgements

This data is solely belongs to https://www.worldometers.info/coronavirus/. for licensing visit https://www.worldometers.info/licensing/

Discover the booming market for oral COVID-19 drugs. This in-depth analysis explores market size, growth projections (CAGR), key players (Pfizer, MSD, Ridgeback, Shionogi), and future trends impacting this dynamic sector. Learn about regional market shares and the factors driving demand for convenient antiviral treatments.

Explore insights from Market Research Intellect's AI To Novel Coronavirus (COVID-19) And Epidemic Market Report, valued at USD 3.5 billion in 2024, expected to reach USD 8.1 billion by 2033 with a CAGR of 10.2% during 2026-2033.Uncover opportunities across demand patterns, technological innovations, and market leaders.

This zile file contains three datasets 1. data for 20 coins before the pandemic 2. data for 20 coins during the pandemic 3. Full sample